Research Paper Volume 14, Issue 11 pp 4839—4857
Identification of biomarkers for immunotherapy response in prostate cancer and potential drugs to alleviate immunosuppression
Figure 6. Survival analysis identified 13 immune-response related genes (IRRGs) significantly related to the prognosis of prostate cancer (PRCA). Patients were divided into a high expression group (H) and low expression group (L) according to the median expression of specific genes.